The additional value of the ApoB test alongside traditional lipid tests is demonstrated by assessing the proportion of patients not diagnosed with dyslipidemia through traditional lipid tests but identified as high-risk for CVD due to elevated ApoB levels, as presented in Figure 2. The gene discussed is APOB; the disease is metabolic syndrome.